American Oncology Institute Gurugram Successfully Treats Rare Blood Disorder in 65-Year-Old Woman
Gurugram: In a groundbreaking medical achievement, the American Oncology Institute (AOI) in Gurugram has successfully diagnosed and treated a 65-year-old woman suffering from Myeloproliferative Neoplasia-Essential Thrombocytosis, a rare and potentially dangerous blood disorder. This condition, marked by an overproduction of platelets in the bone marrow, can lead to severe complications like blood clots and abnormal bleeding.
The patient, who had a history of hypertension, sought treatment after experiencing persistent headaches and mild gum bleeding over four months. Upon examination, her elevated blood pressure and mild gum bleeding prompted further investigation. Blood tests confirmed Essential Thrombocytosis, a subtype of myeloproliferative neoplasia.
Dr AK Dhar, HOD and Medical Oncologist at AOI Gurugram explained, “Essential Thrombocytosis is a rare condition requiring thorough evaluation and specialized treatment. Genetic testing and bone marrow examination were crucial in confirming the diagnosis.”
The treatment involved cytoreductive therapy to reduce platelet production in the bone marrow, combined with antiplatelet agents to manage the condition effectively. This approach significantly reduces the risk of strokes and heart attacks associated with abnormal blood clotting.
Dr Amit Dhawan, RCOO of AOI Gurugram, highlighted the institute’s commitment, saying, “Our team’s expertise and collaborative approach were vital in navigating this complex case. This successful outcome underscores AOI Gurugram’s dedication to providing top-tier medical care, especially for rare and challenging disorders.”
Following the treatment, the patient’s platelet counts normalized, showcasing the effectiveness of the therapy. This case highlights the importance of specialized medical care and reinforces AOI Gurugram’s position as a leading cancer treatment center in North India, offering world-class care and diagnostics.
AOI Gurugram continues to set benchmarks in healthcare, providing exemplary treatment for complex and rare conditions, and reaffirming its status as a premier oncology institute in the region.
About The Author
